NIH COVID-19 deal broadens access for poorer nations

The Medicines Patent Pool (MPP) and World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) have signed a deal aiming to open up new technologies to people living in poorer countries.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

In-house counsel

What's AI best at? In-house teams are still learning

2 October 2026 AI is helping legal and IP teams handle more work without adding headcount, but in-house counsel at LSPN Europe warn that knowing when not to rely on the technology is just as important as knowing how to use it.

In-house counsel

WATCH: Genevant IP director on tackling UPC-EPO opposition divide

1 October 2026 With patent validity increasingly being fought over in both the UPC and EPO, Genevant Sciences’ Stephan Kutik talks to LSIPR about keeping parallel proceedings aligned and why teamwork matters.

Regulation & Industry

5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?

1 October 2026 LSPN Europe made its Basel debut, and two days of conversations showed just how much is changing for life sciences professionals—both in how they work and what they are being asked to do. Marisa Woutersen tallies up the talking points.

More features

What's AI best at? In-house teams are still learning

WATCH: Genevant IP director on tackling UPC-EPO opposition divide

5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?

Lilly loses Fed Circ rehearing bid, sparking enablement questions

Westlaw publisher scores landmark AI copyright win in US appeals court

Scientist and Chinese biotech targeted by Beam in secrets suit

Clifford Chance recruits new head of Asia-Pac

Takeda sees off UK challenge to Elvanse SPC

NIH COVID-19 deal broadens access for poorer nations

More on this story

Editor's picks

Editor's picks

More features